Canada Invests $30.4M in University Research Infrastructure
News Apr 16, 2014
These funds will also go to institutions with researchers working in areas such as pharmacology, infectious disease and materials engineering. The support will provide recipients with advanced tools that will help them generate research breakthroughs, expand Canada’s innovation capacity and contribute to the country’s economic success.
The CFI’s John R. Evans Leaders Fund helps these academic institutions attract and retain some of the world’s most talented researchers in a variety of disciplines.
New biomarkers to detect dementia among innovative projects awarded
The first signs of Alzheimer’s disease in Canada’s aging population may be detected earlier using new biomarkers being developed by Jennifer Heisz, a neuroscientist at McMaster University. Heisz’s brain biomarkers are neural signals she will use to detect disease, or the risk of disease, early and help measure the progress of treatments.
Heisz’s Neurophysiology and Fitness Laboratory is one of 149 facilities at universities across the country to benefit from new federal investments through the Canada Foundation for Innovation’s (CFI) John R. Evans Leaders Fund.
Other approved projects include:
- Liquid Chromatography-Mass Spectrometry (LC-MS) System for Developing Sensitive and Quantitative Proteomics Techniques at Simon Fraser University.
- Biochemical Mechanisms of Epigenetic Inheritance at Université de Montréal
- Single Cell Genomics Infrastructure at McGill University
A full list of approved project can be found below.
Genes Can Influence the Mutation, Activity of Nearby GenesNews
Study shows that a gene’s neighborhood can influence whether and how the activity of a gene changes.READ MORE
Brain Regions Implicated in Mental Disorders Influenced by Neanderthal GenesNews
Findings indicate that the more a person’s genome carries genetic vestiges of Neanderthals, the more certain parts of his or her brain and skull resemble those of humans’ evolutionary cousins that went extinct 40,000 years ago.READ MORE
Acquisition Sees Agilent Gain Powerful NGS IP PortfolioNews
Agilent Technologies announces its acquisition of the molecular and sample barcoding portfolios of Population Genetics Technologies.READ MORE
Comments | 0 ADD COMMENT
International Conference on Genomics and Pharmacogenomics
Jul 18 - Jul 19, 2018
11th Edition of International Conference on Proteomics 2018
Mar 22 - Mar 23, 2018